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A gradually increasing number of transient neonatal zinc
deficiency (TNZD) cases was recently reported, all of which
were associated with inactivating ZnT2 mutations. Here we
characterized the impact of three novel heterozygous ZnT2
mutations G280R, T312M, and E355Q, which cause TNZD in
exclusively breastfed infants of Japanese mothers. We used the
bimolecular fluorescence complementation (BiFC) assay to pro-
vide direct visual evidence for the in situ dimerization of these
ZnT2 mutants, and to explore their subcellular localization.
Moreover, using three complementary functional assays, zinc
accumulation using BiFC-Zinquin andZinpyr-1 fluorescence as
well as zinc toxicity assay, we determined the impact of these
ZnT2 mutations on vesicular zinc accumulation. Although all
three mutants formed homodimers with the wild type (WT)
ZnT2 and retained substantial vesicular localization, as well as
vesicular zinc accumulation, they had no dominant-negative
effect over the WT ZnT2. Furthermore, using advanced bioin-
formatics, structural modeling, and site-directed mutagenesis
we found that these mutations localized at key residues, which
play an important physiological role in zinc coordination
(G280RandE355Q) andzincpermeation (T312M).Collectively,
our findings establish that some heterozygous loss of function
ZnT2 mutations disrupt zinc binding and zinc permeation,
thereby suggesting a haploinsufficiency state for the unaffected
WT ZnT2 allele in TNZD pathogenesis. These results highlight
the burning need for the development of a suitable genetic
screen for the early diagnosis of TNZD to prevent morbidity.
In the past 50 years, the key role of zinc in human health was
established (1). Zinc is crucial for central physiological pro-
cesses including DNA and protein synthesis, enzyme activity,
intracellular signaling, immune function, fertility, as well as
growth and development (1–3). Zinc homeostasis is primarily
regulated by two zinc transporter families as well as by zinc-
binding proteins. The SLC39A gene family encodes for
ZIP1–14 transporters, which are responsible for zinc uptake
into the cytosol from the extracellular fluid or from intracellu-
lar vesicles (4). In contrast, the SLC30A gene family encodes for
the transporters ZnT1–10, which are responsible for zinc
secretion from the cytosol to intracellular organelles or through
the plasma membrane outside the cells (2, 4).
The recent position of the Academy of Nutrition and Dietet-
ics (5) is that breastfeeding in the first 6 months of life can
provide adequate micronutrients and macronutrients for opti-
mal growth and development. This statement is correct for the
vast majority of infants around the world. However, recent
reports indicate that some exclusively breastfed infants suffer
from severe zinc deficiency due to lack of zinc in the breastmilk
they consume (6–11). These cases were referred to as transient
neonatal zinc deficiency (TNZD),4 as the symptoms can be
treated with zinc supplementation to the diet of the infant (12,
13). In contrast to TNZD, which appears only in exclusively
breastfed infants, and will not emerge after weaning, acroder-
matitis enteropathica (OMIM number 201100), an autosomal
recessive disease (12, 14), also presents after weaning, as a result
of loss of function mutations in the SLC39A4 gene (ZIP4).
These inactivating mutations impair intestinal zinc absorption
via the ZIP4 transporter, thereby leading to severe zinc defi-
ciency after weaning. This zinc deficiency can lead to death in
the absence of adequate zinc supplementation (13). To date,
eight loss of functionmutationswere identified in the SLC30A2
(ZnT2) gene, which cause TNZD (6–11) (OMIM number
608118) and at least 20 cases of infants with TNZD were
reported in the past eight years in Japan (11). Current data sug-
gest that 36% of 54 women who were tested had an exon varia-
tion in the SLC30A2 gene, and exhibit inadequate or excess zinc
levels in their breast milk (15).
The SLC30A2 gene encodes for the zinc transporter ZnT2,
which is responsible for zinc accumulation in intracellular ves-
icles, in lactating epithelialmammary gland cells. Through exo-
cytosis, these zinc-loaded vesicles secrete zinc into breast milk
(13). The molecular mechanisms that were found to be causa-
tive of TNZD included aggresomal accumulation (6), domi-
nant-negative effect (8, 16, 17), frameshift mutation, which
causes premature translation termination (9), disruption of
homodimer formation (7), and enhanced degradation of ZnT2
(7). Excluding one case of compound ZnT2 mutations (7), all
TNZD cases reported to date were found in mothers that were
heterozygous for mutations in the SLC30A2 gene.
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We recently applied the bimolecular fluorescence comple-
mentation (BiFC) assay to provide the first evidence for the
homo- and heterodimerization of various members of the ZnT
family (16, 17). Here we employed this BiFC technique along
with an advanced bioinformatics analysis, using three-dimen-
sional modeling, which is based upon the crystal structure of
the bacterial YiiP, a ZnT homologue from Escherichia coli, to
functionally characterize three novel mutations in the ZnT2
(SLC30A2) gene, which were recently shown to cause TNZD in
Japanese infants (11). These novelZnT2mutations provide new
insight into the structure and function of the C terminus of
ZnT2 transporterwith emphasis on the disruption of zinc bind-
ing and zinc permeation capacity. These novelmutationsmark-
edly expandour knowledge regarding structural ZnT2determi-
nants of zinc binding and transport.
Materials andMethods
Chemicals and Reagents—The DNA dye Hoechst 33342 was
purchased from Sigma. The viable fluorescent zinc probe Zin-
quin ethyl ester was purchased from Biotium (Hayward, CA),
whereas zinc sulfatewas obtained fromMerck. The second zinc
probe, Zinpyr-1 ester was purchased from Santa Cruz Biotech-
nology (Santa Cruz, CA).
Expression Vector Construction—Expression plasmids used
to express C terminally HA- or FLAG-tagged ZnT2 were con-
structed by inserting the cDNA into the pA-puro or pA-Neo
vectors. For zinc toxicity assay the introduction of a mutation
into ZnT2 cDNAwas carried out by the two-step PCRmethod,
and amplified cDNAs were sequenced in both directions. The
primers for the introduction of ZnT2 mutations are listed in
Table 1. ZnT2 BiFC constructs were generated as previously
described (17). The mutations were introduced into the ZnT2
expression plasmids using Pfu Turbo DNA polymerase
(QuikChange kit, Stratagene, La Jolla, CA) and the primers
listed in Table 1. Plasmid containing the ER marker -subunit
of the signal recognition receptor tagged with CFP (SR-CFP)
was kindly provided by Hirschberg Koret (Tel-Aviv University,
Israel).
Stable Expression of ZnT2 Protein in DT40 ZnT1/MT/
ZnT4/ Cells—For electroporation, chicken B lymphocyte-
derived DT40 cells deficient in ZnT1, metallothionein (MT),
and ZnT4 genes (ZnT1/MT/ZnT4/ cells) (2  107)
were suspended in 0.5 ml of PBS containing 25 g of linearized
DNA. DNA was electroporated into the cells by Gene Pulser
Xcell (Bio-Rad) under conditions of 550 V and 25 F with a
0.4-cm gap electroporation cuvette. After electroporation, cells
were transferred into 30 ml of growth medium and incubated for
24 h. Cells were then resuspended in 60 ml of growth medium
containing 0.5 g/ml of puromycin (Sigma) or 2 mg/ml of G418
(Sigma) and divided into three 96-well plates. After 10 days, drug-
resistant clones were transferred to 24-well plates in 1ml of selec-
tion medium and cultured for 2 days. Expression of ZnT2 was
confirmedbyWesternblot analysis.More than three independent
clones per transfection were picked.
Western Blotting Analysis—The blotted PVDF membrane
(Immobilon-P, Millipore Corp., Bedford, MA) was blocked
with a solution of 5% skimmed milk and 0.1% Tween 20 in PBS
prior to incubation with anti-DDDDK tag (1:4,000, MBL,
Nagoya, Japan, PM020), anti-HA HA-11 (1:4,000, Covance,
Emeryville, CA, MMS-101P), anti-ZnT2 (7) (1:4,000 dilution),
or anti--tubulin (1:10,000, Sigma, T7816) antibodies in block-
ing solution. Horseradish peroxidase-conjugated anti-mouse
(GE Healthcare, NA931) or anti-rabbit (GE Healthcare,
NA934) secondary antibodies, were added at a 1:4,000 dilution
for detection. The fluoro-image was obtained using LAS1000
plus (Fujifilm, Tokyo, Japan).
Transient Transfections—MCF-7 breast cancer cells were
grown and transiently transfected as previously described (17).
Cells were seeded in 12-well plates (105 cells/well; Nunc A/S,
Roskilde, Denmark) for flow cytometry studies. For fluores-
cence microscopy cells were seeded (2  105 cells/well) in
24-well glass bottom plates (In Vitro Scientific, Sunnyvale, CA)
with 1ml of growthmedium containing the transfection reagents
and plasmids. Cells were transiently transfected (0.5 g of ER
marker plasmidDNA 0.5g of BiFC constructs/well, total 1g
of DNA/well) using linear polyethylenimine (Mr 25,000) trans-
fection reagent (Polysciences, PA) at a ratio of 3:1g of polyethyl-
enimine:DNA, and were incubated for up to 24 h before imaging.
Evaluation of ZincTransportActivity of ZnT2Mutants Based
on a Viability of Zinc-sensitive DT40 ZnT1/MT/
ZnT4/Cells againstHigh Levels of Extracellular Zinc—DT40
ZnT1/MT/ZnT4/ cells were cultured in RPMI 1640
(Nacalai Tesque, Kyoto, Japan) supplemented with 10% (v/v)
TABLE 1
Primers used to introduce site-directed mutations into the human ZnT2 cDNA at amino acid positions Gly-280, Thr-312, and Glu-355
Experiment Name Forward sequence (5 to 3) Reverse sequence (5 to 3)
Zinc toxicity assay ZnT2 G280R GTGTTGATGGAAAGGACCCCCAAGGGC GCCCTTGGGGGTCCTTTCCATCAACAC
ZnT2 G280A GTGTTGATGGAAGCTACCCCCAAGGGC GCCCTTGGGGGTAGCTTCCATCAACAC
ZnT2 G280T GTGTTGATGGAAACGACCCCCAAGGGC GCCCTTGGGGGTCGTTTCCATCAACAC
ZnT2 G280L GTGTTGATGGAACTGACCCCCAAGGGC GCCCTTGGGGGTCAGTTCCATCAACAC
ZnT2 G280Q GTGTTGATGGAACAGACCCCCAAGGGC GCCCTTGGGGGTCTGTTCCATCAACAC
ZnT2 G280K GTGTTGATGGAAAAGACCCCCAAGGGC GCCCTTGGGGGTCTTTTCCATCAACAC
ZnT2 T312M ATCTGGGCACTGATGGTGGCCCAGCCT AGGCTGGGCCACCATCAGTGCCCAGAT
ZnT2 T312A ATCTGGGCACTGGCGGTGGCCCAGCCT AGGCTGGGCCACCGCCAGTGCCCAGAT
ZnT2 T312S TGGGCACTGAGCGTGGCCCAG CTGGGCCACGCTCAGTGCCCA
ZnT2 T312C ATCTGGGCACTGTGCGTGGCCCAGCCT AGGCTGGGCCACGCACAGTGCCCAGAT
ZnT2 T312E TGGGCACTGGAGGTGGCCCAG CTGGGCCACCTCCAGTGCCCA
ZnT2 T312D TGGGCACTGGACGTGGCCCAG CTGGGCCACGTCCAGTGCCCA
ZnT2 E355Q GTGACCATCCAGATCCAGGACTACTCGGAG CTCCGAGTAGTCCTGGATCTGGATGGTCAC
ZnT2 E355A ACCATCCAGATCGCTGACTACTCGGAG CTCCGAGTAGTCAGCGATCTGGATGGT
ZnT2 E355D ACCATCCAGATCGACGACTACTCGGAG CTCCGAGTAGTCGTCGATCTGGATGGT
BiFC assay ZnT2 G280R GTGATCCTGGTGTTGATGGAAAGGACCCCCAAGGGCGTTGAC GTCAACGCCCTTGGGGGTCCTTTCCATCAACACCAGGATCAC
ZnT2 T312M GCACTGATGGTGGCCCAGCCTGTTCTG CAGAACAGGCTGGGCCACCATCAGTGC
ZnT2 E355Q ATCCAGATCCAGGACTACTCGGAGGAC GTCCTCCGAGTAGTCCTGGATCTGGAT
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heat-inactivated fetal calf serum (FCS; Multiser, Trace Scien-
tific, Melbourne, Australia), 1% (v/v) chicken serum (Invitro-
gen), and 50 M 2-mercaptoethanol (Sigma) at 39.5 °C as pre-
viously described (7, 18). ZnT1/MT/ZnT4/ cells failed
to grow in the presence of60 M ZnSO4 (7, 18). To evaluate
cell viability in the presence of increasing extracellular zinc
concentrations, cells were cultured in the presence of 50–100
M ZnSO4 for 72 h. Viable cell numbers were determined by
trypan blue exclusion, and relative cell viability was determined
as previously described (7). Relative values presented are eval-
uations of the averages of three independent experiments. Each
evaluation was performed at least three times.
Fluorescence Microscopy—Twenty-four h after transfection,
the growth medium was removed and monolayer cells were
washedwith PBS and incubated in PBS containing 1mMMgCl2,
1 mM CaCl2, and 10 mM D-glucose, pH 7.4. Hoechst 33342 (2
g/ml) was used for nuclear DNA staining. Live cells were
imaged using an inverted confocal microscope (Zeiss LSM 710)
at a magnification of63 under immersion oil.
Flow Cytometry—For the BiFC-Zinquin assay, transiently
transfected MCF-7 cells were analyzed by flow cytometry for
both YFP fluorescence as well as fluorescence of the viable zinc
probe, Zinquin, as previously described (16). In addition,
ZnT1/MT/ZnT4/ cells stably expressing each ZnT2
mutant were grown in the presence or absence of 30MZnSO4
for 48 h then treatedwith 5MZinpyr-1 ester for 30min before
being analyzed by flow cytometer as previously described (11).
BiFC Terminology—YN and YC represent the N- and C-ter-
minal halves of YFP, respectively. Transfection with the con-
struct-YC-YN implies that plasmids containing both the con-
struct-YN and construct-YC were co-transfected into cells.
Structural Modeling of Human ZnT2—ZnT2 monomer
modelwas aligned to the 3h90 template (PDB code 3h90, chains
A and C) using the HHpred method (19), and its three-dimen-
sional structure modeled by MODELLER software (20) using
the HHpred interface. To obtain the ZnT2 dimer, we per-
formed structural alignment of two identical modeled mono-
mers of ZnT2 with two crystal structures of YiiP monomers,
which form one of the two unit cell dimers. Then, mutations
were introduced with Swapaa in Chimera UCSF (21), and visu-
alized with its interface. The three-dimensional structural
model of the ZnT2 dimer was obtained by superimposing two
monomers of the ZnT2 model into the 3h90 dimer, using the
MatchMaker tool on Chimera UCSF (21, 22). Because the
mutations are on the cytoplasmic domain, structural alignment
was performed using only this region formaximal accuracy. For
that purpose, we used only 82 residues from the C-terminal
cytoplasmic domain of both molecules, corresponding to
amino acids 359–278 inZnT2 and 287–206 inYiiP, because the
three mutations in this study were mapped to the cytoplasmic
region and local comparison of corresponding residues is more
accurate with this structural alignment. This procedure yielded
a very good root mean square deviation of 0.455 (compared
with a root mean square deviation 0.697 Å for the full model).
Subsequent analyses of the localization and possible impact of
mutationswere undertakenwith the dimermodel of the human
ZnT2 obtained. Stability calculations of the ZnT2 monomer
upon introduction of individual mutations were carried out
with FoldX (23) and DUET (24) servers.
FoldX is a computational method that provides quantitative
estimation of the importance of the interactions contributing to
the stability of proteins. It provides an estimation of the free
energy (in kcal/mol). FoldX predictions are relevant when the
energy difference can be calculated between two well defined
structures, such as between the WT and a mutant. The differ-
ence in the calculated free energies (G) between the final
state (the mutant) and the reference state (the WT protein)
correlates well with the experimentally observed change in sta-
bility (23).
DUET is an integrated computational approach for the
assessment of the impact of missensemutations on protein sta-
bility. DUET combines mCSM and SDMmethods in a consen-
sus prediction, by consolidating the results of the separate
methods in an optimized predictor using support vector
machines trained with Sequential Minimal Optimization (24).
Molecular graphics and analyses were performed with the
UCSF Chimera package (21).
MatchMaker extension (22) of Chimera UCSF is a structural
alignment tool that works by first constructing a pairwise
sequence alignment and then used to superimpose the struc-
tures. The fit can be improved iteratively by pruning residue
pairs far apart in space.
AreaSAS Attribute (on Chimera UCSF)—The solvent-acces-
sible surface area was available when a molecular surface was
computed. Swapaa command inUCSFChimera replaces amino
acid side chains using information froma rotamer library. Rota-
mers can be chosen automatically based on the lowest clash
score, mostly H-bonds, best fit to an electron density map,
and/or highest probability according to the library, or interac-
tively from a rotamer list.
HHpred server (19) for the protein remote homologue detec-
tion and three-dimensional structure prediction is a sequence
database searching and structure prediction algorithm that is
much more sensitive than BLAST in identifying remote
homologues. HHpred can produce pairwise query-template
sequence alignments, merged query-template multiple align-
ments (e.g. for transitive searches), as well as three-dimensional
structural models calculated by theMODELLER software from
HHpred alignments with very low sequence identity.
Statistical Analysis—Results are presented as mean  S.D.
Statistical comparisons were performed using Student’s t test
(Prism GraphPad, Berkeley, CA), and a significant difference
was demonstrated when p was  0.05. Results from at least
three independent experiments are shown.
Results
The TNZD Mutations G280R, T312M, and E355Q Retain
ZnT2 Homodimerization—We first assessed the ability of the
ZnT2 mutants to form homodimers using the BiFC assay and
flow cytometric analysis. In this respect, we determined two
parameters. (a) The percentage of cells displaying YFP fluores-
cence and (b) the median cellular YFP fluorescence. These
parameters reflected the ability of ZnT2 monomers (ZnT2-YC
and ZnT2-YN) to form homodimers. Consequently, the two
non-fluorescent halves of the YFP protein refolded and yielded
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a strong YFP fluorescence signal. The ZnT2 mutants G280R,
T312M, and E355Q neither significantly diminished the per-
centage of cells displaying YFP fluorescence nor the median
YFP fluorescence compared with theWT-ZnT2 (Fig. 1). These
results indicate that none of these ZnT2 mutations interfered
with the homodimerization capacity. Moreover, this YFP fluo-
rescence was preserved when cells were co-transfected with
YC-YN pairs of a given mutant plasmid (G280R-YC-YN,
T312M-YC-YN, or E355Q-YC-YN) as well as upon co-transfec-
tion of a single mutant along with WT-ZnT2-YN (G280R-
YCZnT2-YN, T312M-YCZnT2-YN, or E355Q-YCZnT2-YN).
These results are consistent with a previous co-immunopre-
cipitation analysis, indicating that these ZnT2mutants interact
with the WT-ZnT2, hence corroborating the preservation of
homodimerization of these ZnT2 mutants (11).
CertainZnT2MutationsAlter the Subcellular Localization of
ZnT2 Homodimers—MCF-7 cells were transiently co-trans-
fected with WT or mutant ZnT2 BiFC constructs, and were
analyzed using confocal microscopy to explore the impact
of the mutations on the subcellular localization of ZnT2
homodimers (as summarized in Table 2). WT-ZnT2
homodimerswere found to localize in intracellular vesicles (Fig.
2, a–c), which are responsible for zinc accumulation as previ-
ously shown (16). In contrast, the G87R-ZnT2 dominant-neg-
ative TNZDmutant was retained in the ER as evident from the
co-localization of G87R-ZnT2 with SR-CFP, an established
ER marker (Fig. 2, d–f). Similarly, most of the fluorescent
G280R-YC-YN dimers were localized at the ER network (Fig. 2,
j–l) and failed to reach their physiologic secretory vesicles des-
tination. Homodimers of G280R-YCWT-ZnT2-YN were
found to localize at the ER in a large fraction of transfectant cells
(Fig. 2, g–i). However, some vesicular localization was also
observed indicating that some of these homodimers reached
their physiologic vesicular destination, and could potentially
contribute to vesicular zinc accumulation. These findings sug-
gest that upon homodimerization, themutant G280R alters the
subcellular localization of the WT ZnT2; however, in contrast
to the G87R mutant (8, 17), G280R did not fully abolish the
ability of the WT-ZnT2 to reach its intracellular vesicular des-
tination. In contrast, approximately half of the cells transfected
with themutant T312M-YC-YN showed vesicular localization,
whereas the remaining fraction of cells displayed ER retention
(Fig. 2, p–r). These results suggest that mutant-mutant T312M
ZnT2 homodimers significantly retained some of their native
vesicular localization. Furthermore, T312M-YCWT-ZnT2-YN
dimers were localized predominantly in intracellular vesicles
(Fig. 2,m–o), suggesting that the T312M mutant has little del-
eterious effect on the localization of the WT-ZnT2 upon
dimerization. Finally, E355Q-YC-YN dimers displayed a pre-
dominant ER retention (Fig. 2, v–x), whereas E355Q-YCWT-
ZnT2-YN homodimers exhibited a vesicular localization in a
large fraction of transfectant cells (Fig. 2, s–u), when compared
with the mutant-mutant pairs. These results suggest that the
E355Q mutation has a deleterious effect on the native subcel-
lular localization of WT-ZnT2 upon homodimerization.
G280R, T312M, and E355QMutants Disrupt Zinc Transport
but Do Not Exert a Dominant-negative Effect Over the WT
ZnT2—To assess the functionality of the mutant ZnT2 dimers,
flow cytometry dot plot analysis was undertaken to compare
YFP fluorescence versus the fluorescence of Zinquin, a viable
cellular zinc probe (Fig. 3). The background autofluorescence
dot plot of non-transfected cells defined the quadrant position.
The upper quadrants (left and right) represent cells displaying
YFP fluorescence above the background level, hence being
indicative of intact formation of ZnT2 homodimers. The upper
right quadrant reflects cells displaying YFP and Zinquin fluo-
rescence levels above the background. To calculate Zinquin
accumulation (shown in Fig. 4), we divided the percentage of
cells displaying YFP and Zinquin fluorescence (upper right
quadrant) by the percentage of cells displaying YFP fluores-
cence (upper quadrants). When WT-ZnT2-YC-YN constructs
were co-transfected, a large fraction (	40%) of cells were in the
upper right quadrant, and only a small fraction (
20%) was at
the upper left quadrant (Fig. 3b). These results demonstrate
that from a total of 60% of cells displaying YFP fluorescence, the
majority accumulated Zinquin. Hence, this indicated the func-
tionality of WT-ZnT2 homodimers in zinc accumulation (Fig.
3b). Importantly, the dot plots clearly demonstrate the func-
tional differences between WT-ZnT2 and the different ZnT2
mutants; in contrast to the WT-ZnT2-YC-YN transfection,
when bothYC andYNconstructs ofZnT2weremutated (Fig. 3,
c, e, and g), most of the cells were located at the upper left
quadrant, indicating a very low Zinquin accumulation, as a
result of the loss of vesicular zinc transport (Fig. 3, c, e, and g).
These results were similar to transfection with the empty YFP
vector (Fig. 3i), which was used as a negative control for lack of
zinc transport activity. However, when WT-ZnT2-YN was co-
transfected together with mutant-ZnT2-YC constructs, there
was a shift toward the upper right quadrant (Fig. 3, d, f, and h),
indicating the rescue of the zinc transport function by theWT-
mutant pairs, when compared with the mutant-mutant ZnT2
dimers that were inactive in zinc transport (Fig. 3, c, e, and g).
Similar results were obtained when WT-ZnT2-YC was trans-
FIGURE 1.ZnT2mutants formhomodimersbasedonBiFCanalysis.MCF-7
cells were transiently co-transfected with YC- and YN-tagged ZnT2 plasmid
pairs or with 2AR-YN as detailed below in the x axis. The percentage of
transfected cells displaying YFP fluorescence (black bars) and themedian YFP
fluorescence (gray bar) were determined using flow cytometry and represent
the fraction of ZnT-YC-YN positive cells. The negative controls consisted of
co-transfection with ZnT2-YC and 2AR-YN. All p values (p 0.05) revealed
statistically significant differences when comparedwith the negative control
of ZnT2-YC2AR-YN. All p values (p 0.05) of the differentmutants did not
display any statistically significant differences when compared with
WT-ZnT2-YC-YN. Error bars represent S.D.
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FIGURE 2.Subcellular localizationofWTZnT2andmutant homodimers.MCF-7 cellswere transiently co-transfectedwith the constructs described at the left side
of the tripletpanels. In addition, cellswereco-transfectedwith theconstructof theERmarker, the subunitof signal recognition receptor taggedwithCFP (SR-CFP),
leftpanels. ThegreenYFP fluorescencesignal (YC-YNfluorescence)at themiddlepanels indicatesdimer formation.Hoechst33342 (blue fluorescence)wasusedtostain
nuclei. LiveMCF-7 cells were examined using confocal (LSM 710) fluorescencemicroscopy. Amagnification of63 under immersion oil was used.
FIGURE 3. Flow cytometry dot-plot analysis was undertaken to assess the functionality of the ZnT2mutants. Shown are flow cytometry dot-plots from
one representative experiment. MCF-7 cells were transiently co-transfected with the constructs described above the dot-plots. The y-axis represents the YFP
fluorescence,whereas the x-axis denotesZinquin fluorescence levels. Eachdot represents a single cell. Quadrantsweredeterminedusing theautofluorescence
dot-plot. Upper quadrants represent all cells displaying an YFP fluorescence level that was above the autofluorescence signal (transfected cells). Right quad-
rants represent all cells displaying Zinquin fluorescence. Upper-right quadrants represent cells exhibiting both YFP signal and Zinquin staining.
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fected together with mutant-ZnT2-YN constructs (data not
shown). This dot plot analysis highlights the differences
between different ZnT2 mutants and the WT transporter in
Zinquin accumulation and the major deleterious effect these
mutations have on zinc transport.
We next determined Zinquin fluorescence intensity and cel-
lular accumulation levels in the different ZnT2 variants using
flow cytometry (Fig. 4). We found that Zinquin accumulation
levels (Fig. 4, black bars) obtained with the mutant-mutant
pairs (i.e.G280R-YC-YN,T312M-YC-YN, and E355Q-YC-YN)
were not significantly different from the Zinquin accumulation
levels of the empty vector transfection. These results highlight
the major deleterious effect that these TNZD mutations have
on the zinc transport capacity of ZnT2. In contrast, when
WT-ZnT2-YN was co-transfected with one of the mutants,
G280R-YC, T312-YC, or E355Q-YC, the presence of the WT-
ZnT2 transporter significantly improved Zinquin accumula-
tion when compared with the empty vector; albeit, they did not
attain the Zinquin accumulation levels of the WT-ZnT2 pairs
(Fig. 4, left-most column, black bars). Furthermore, in all co-
transfectionswithmutant andWTZnT2, Zinquin fluorescence
levels were significantly higher when compared with the empty
vector (Fig. 4, gray bars). These results indicate that these ZnT2
mutants did not exert a dominant-negative effect over theWT-
ZnT2, as Zinquin accumulation levels and fluorescence levels
were significantly higher when the mutant was expressed
together with the WT-ZnT2.
To further explore the impact of each of the threemutants on
the function of theWT-ZnT2 upon co-expression, hencemim-
icking the heterozygous mutation found in the mothers of
TNZD patients, we used a cell-based zinc toxicity assay in
DT40 cells that lack ZnT1, metallothionein, and ZnT4
(ZnT1/MT/ZnT4/) as previously described (7, 18).We
compared the viability of cells stably expressing WT-ZnT2
and/or mutant ZnT2 upon a cytotoxic challenge of increasing
zinc concentrations. Moreover, the ability of the different
mutants to protect cells against zinc toxicity was compared
with the G87R-ZnT2mutant, which we have previously shown
to exert a dominant-negative effect over the WT-ZnT2 (8, 17).
When different tagged WT-ZnT2 was expressed alone, cells
survived up to a concentration of 100 M ZnSO4, hence reca-
pitulating the key protective role of ZnT2 via vesicular zinc
compartmentalization (Table 3). In contrast, single ectopic
gene expression of each of the ZnT2 mutants, including G87R,
G280R, T312M, and E355Q, did not confer upon cells any pro-
tective effect against ZnSO4 and all cells died when exposed to
	60 M ZnSO4 as previously shown (Table 3). Co-expression
of WT-ZnT2 along with G87R-ZnT2 slightly improved the
ability of cells to tolerate high zinc levels, up to 80 M ZnSO4
(Table 3). The expression levels of G87R-ZnT2 were relatively
low when compared with the WT-ZnT2 protein, although the
total ZnT2 expression levels in these cells were higher than that
in the cells expressing the WT-ZnT2 alone (Fig. 5). These
results suggest that the dominant-negative effect of G87R over
the WT protein is even more significant when considering its
low expression level. Surprisingly, in contrast to the G87R-
ZnT2, co-expression of the WT-ZnT2 along with single
mutants, including G280R-ZnT2, T312M-ZnT2 and E355Q-
ZnT2, substantially improved the ability of cells to tolerate high
zinc levels up to 100 M ZnSO4. Zinc tolerance activity in cells
co-expressing WT-ZnT2 and the E355Q mutant was the same
as in cells expressing the WT-ZnT2. Co-expression of WT-
ZnT2 together with G280R or T312M appeared to provide zinc
torelance activity, which was slightly lower than WT-ZnT2
expression (Table 3). These three stably expressing transfec-
tants displayed a better zinc tolerance capacity when compared
with the co-expression of the WT-ZnT2 and G87R. The
expression levels of G280R-ZnT2 and E355Q-ZnT2 were fur-
ther evaluated using Western blotting analysis and were found
to be relatively lower thanWT-ZnT2 levels in cells co-express-
ing bothmutants (Fig. 5). Thismay suggest that in these cells, in
contrast to the dominant-negative effect we observed with the
G87R mutant, more active homodimers of WT-ZnT2 were
formed, which presumably better protected the cells from zinc
FIGURE 4. Zinquin accumulation assay reveals the disruption of zinc
transport function invariousZnT2mutantsassociatedwithTNZD.MCF-7
cells co-transfectedwith the constructs depicted along the x axis were exam-
ined for Zinquin fluorescence levels (gray bars) as well as the percentage of
transfected cells displaying Zinquin fluorescence (dark bars). The percentage
of Zinquin accumulation was calculated by dividing the fraction of YFP fluo-
rescent cells (YC-YN) displaying Zinquin fluorescence by the total fraction of
cells displaying YFP fluorescence (YC-YN). Asterisks indicate that the values
obtainedwere significantly different (p 0.05) when comparedwith the YFP
empty vector. Error bars represent S.D.
TABLE 3
Cell-based zinc toxicity in DT40 cells stably transfected with various
site-directed ZnT2 TNZDmutants
The viability of cells exposed to the indicated concentrations of ZnSO4 for 72 h was
determined by determining the number of viable cells using Trypan blue exclusion.
The results of single transfectant cells (G87R, G280R, T312M, or E355Q) were
recently published (7). Relative values presented are evaluations of the average val-
ues of three independent experiments.
Expressed ZnT2
ZnSO4 (M)
50 60 70 80 90 100
DT40 ZnT1/MT/ZnT4/ cells
Untransfected a     
WT-HA      
G87R-HA      
G280R-HA      
T312M-HA      
E355Q-HA      
DT40 ZnT1/MT/ZnT4/ cells
WT-HAWT-FLAG      
WT-FLAG G87R-HA      
WT-HA G280R-FLAG      
WT-HA T312M-FLAG      
WT-HA E355Q-FLAG      
a The symbols represent:: growing to confluence;,: decreased growth
(20–50% or up to 20% relative to);, no growth.
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toxicity. These results (summarized in Table 2) lend further
support to the Zinquin accumulation results and indicate that
the G280R, T312M, and E355Q mutants did not exert a domi-
nant-negative effect over the WT-ZnT2 as did the mutant
G87R, although it was considered that they may exert a domi-
nant-negative effect in a previous study (11).
Evaluation of the Impact of the Mutations on the Structure
and Function of Human ZnT2—We undertook in silico muta-
tion studies with three complementary approaches. (a) Using
the ZnT2 dimer model and in silico introduction of the muta-
tions using the Swapaa tool from UCSF Chimera (see ”Materi-
als and Methods“), we analyzed the energetic stability of the
mutationswhen comparedwith theWT-ZnT2using theDUET
and FoldXmethods. (b) Comparing themutation positions and
environment with the corresponding YiiP residues. (c) Analyz-
ing the impact on zinc binding, of the ZnT2 mutations, which
are in close proximity to zinc ions in the YiiP crystal structure.
The threemutations includingG280R, T312M, and E355Q (11)
were found to localize at sites critical for the zinc transport
function of ZnT2 as shown in our three-dimensional model
(Fig. 6) and as discussed below.
The G280R Mutation—Gly-280 is located in a loop between
the last transmembrane (TM) helix and a cytoplasmic domain
FIGURE 5. Co-expression levels of WT andmutant ZnT2 in DT40 ZnT1/
MT/ZnT4/ cells. Confirmation of stable co-expression of WT and
mutant ZnT2 in DT40 ZnT1/MT/ZnT4/ cells. Western blotting analysis
was performed using antibodies against HA tag, FLAG tag, ZnT2, and-tubu-
lin. Total cellular protein aliquots (10g)were loadedonto each lane, and the
same membrane was used for detection of ZnT2-HA, ZnT2-FLAG, and -tu-
bulin. -Tubulin is shown as a loading control.
FIGURE 6. Three-dimensional structural modeling of the human ZnT2. The ZnT2monomermodel was aligned to the PDB code 3h90 template by the
HHpred method as described under ”Materials and Methods.“ (a) monomer ribbons are colored in cyan and tan, respectively, and the positions of the
various ZnT2 mutations are shown in CPK (Corey-Pauling-Koltun) representation (available in Chimera), where carbon atoms are colored in gold and
green for the two different monomers, respectively. Zinc ions from the YiiP model are shown (for approximate location only) in blue CPK balls. (b) the
Microenvironment of Gly-280 in the human ZnT2 model; the carbon atoms of Gly-280 are colored in gold. (c) The environment of Thr-312 in the human
ZnT2 model. (d) The environment of Glu-355 in the human ZnT2 model; the proximity to the two zinc atoms from the YiiP crystal structure and the two
histidine residues (which are also present on YiiP), strongly suggests that Glu-355 is directly involved in zinc coordination. Themutation sites are colored
in gold. Carbons of the ZnT2 model colored in cyan and carbons of the YiiP colored in gray. Oxygen atoms are colored in red and nitrogen atom in blue.
Zinc atoms are colored in violet.
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in both the YiiP and ZnT2 structures. As evident from Fig. 6, a
and b, and as revealed by surface accessibility calculated by
Chimera (attribute areaSAS), residue Gly-280 is exposed to the
solvent. The Gly-280 residue is located close to zinc coordina-
tion site B in YiiP (25). Although site B is not conserved in
ZnT2, and therefore one cannot infer from our model that a
zinc coordination site exists in ZnT2 near Gly-280. However,
we note that the corresponding residue in the YiiP structure is
an Arg (Arg-208), which interacts and stabilizes site B electro-
statically (the distance of Arg-208 to zinc is 6.8 Å). Thus, inter-
estingly, this mutation of glycine to arginine in ZnT2 is para-
doxically disturbing the delicate balance of electrostatic
properties in that region in ZnT2 that has evolved differently
from YiiP, hence no longer allowing a charged residue in this
position. However, the mutant arginine residue in ZnT2 (i.e.
G280R) introduces an unnecessary positive charge, and a very
large side chain whose size and bulk are expected to result in
steric clashes with the second ZnT2 monomer. Additionally,
we noticed that in ZnT2 there is a unique Arg-126 on the oppo-
site side of the binding site (Gln-65 in YiiP) within almost the
same distance of the zinc atom from the YiiP model as Arg-208
(Fig. 6b). This Arg-126 in ZnT2 may elicit the same stabilizing
role of Arg-208 in YiiP. Therefore, we suggest the existence of a
distinctly evolved zinc coordination site in ZnT2 formed by
Met-132 and Trp-136 as well as Arg-126, instead of corre-
sponding residues His-71, His-75, and Arg-208 in YiiP. Clearly,
theG280Rmutation in ZnT2 certainly introduces an additional
unnecessary positive charge and presumably impairs proper
electrostatic zinc coordination. Alternatively, if no direct zinc
coordination site exists, the G280R mutation is expected to
disrupt dimer formation and subcellular localization (also
based on electrostatics and steric changes, and as evident from
our BiFC assay, Fig. 2) or to reduce zinc transport turnover (i.e.
additional positive charge will repel positive zinc ion in its out
of the TM region en route out of the ER lumen). This is in fact
themutation that is predicted to exert themost profound ener-
getic destabilization impact on the ZnT2 monomer (Table 4),
which suggests a strong impact on protein stability, dimer for-
mation, subcellular localization, and ultimately zinc transport.
The T312M Mutation—This mutation maps to a loop
between -sheets of a cytoplasmic domain of ZnT2, being in
close proximity to TMhelices. However, Thr-312 is completely
buried and points toward the inner channel of the TM domain.
The methionine residue is more hydrophobic and slightly
larger than threonine. Notably, Thr-312 (Ser-239 in YiiP) forms
a cluster with the surrounding residues Glu-140 (Glu-79 in
YiiP), Arg-72 (Arg-11 in YiiP), and Gln-137 (Gly-76 in YiiP) in
ZnT2 (Fig. 6c), which are polar amino acids and highly con-
served as well as very tightly packed and hence are likely impor-
tant for zinc transport. On the YiiP structure, the equivalent
position to the cluster centered on Thr-312 in ZnT2 is very
similar and identical in nearby residues Glu-140 (Glu-79 in
YiiP) and Arg-72 (Arg-11 in YiiP), suggesting that they play a
conserved functional role, probably in zinc transport. This is
the mutation predicted to have the least impact on protein
monomer stability (Table 4) and as revealed by the cyclohexi-
mide protein stability assay, which showed that the T312M
ZnT2 is the most stable protein when compared with G280R
and E355Q (11), suggesting a direct effect on the charge of the
local structure or coordination of zinc along the zinc perme-
ation pathway (Fig. 6, a and c).
The E355Q Mutation—Glu-355 is a completely solvent-ex-
posed residue (as calculated by areaSAS, its exposed surface
area inChimera is very large) and presumably involved in direct
coordination of zinc, on the equivalent site C of YiiP (25). Its
conserved structural partner Asp-285 (and two conserved His
residues) inYiiP is in close contactwith one of the zinc ions (Fig.
6 d). Hence, its substitution to glutamine is expected to produce
a pronounced deleterious impact on zinc coordination and
consequently zinc transport. The E355Q mutation is also pre-
dicted to impact monomer stability but less than G280R (Table
4), because glutamate and glutamine residues are very similar,
and therefore should not affect dimer formation (Fig. 6a);
indeed, the BiFC assay confirmed that the E355Qmutation did
not interfere with its homodimerization capacity (Fig. 1).
Mutational Analysis of the Gly-280, Thr-312, and Glu-355
Residues—To further corroborate the functional role of the
Gly-280, Thr-312, and Glu-355 residues we performed muta-
tional analysis using cell-based zinc toxicity assay in DT40
ZnT1/MT/ZnT4/ cells (Table 5). In addition, we eval-
uated the zinc accumulation ability of these cells using the
TABLE 5
Zinc toxicity assay with site-directed mutations at positions Gly-280,
Thr-312, and Glu-355
The viability of cells exposed to the indicated concentrations of ZnSO4 for
72 h, was determined by counting the number of viable cells using Trypan blue




50 60 70 80 90 100
DT40 ZnT1/MT/ZnT4/ cells
Untransfected a     
WT-HA      
DT40 ZnT1/MT/ZnT4/ cells
G280R-HA      
G280A-HA      
G280T-HA      
G280L-HA      
G280Q-HA      
G280K-HA      
DT40 ZnT1/MT/ZnT4/ cells
T312M-HA      
T312A-HA      
T312S-HA      
T312C-HA      
T312D-HA      
T312E-HA      
DT40 ZnT1/MT/ZnT4/ cells
E355Q-HA      
E355A-HA      
E355D-HA      
a The symbols represent:, cells growing to confluence;,, decreased
cell growth (20–50 or up to 20% relative to);, no growth.
TABLE 4
Predicted thermodynamic destabilization of ZNT2 human monomer
uponmutation expressed as the variation in Gibbs’ free energy (G)
in Kcal/mol
Positive values indicate stabilizing mutations while negative values denote destabi-
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selective zinc probe Zinpyr-1 and flow cytometry (Fig. 7).
Expectedly, substitution of glycine 280 to alanine (G280A) fully
preserved the ability of cells to protect themselves against zinc
toxicity (Table 5) and accumulate Zinpyr-1 (Fig. 7a). This abil-
ity was partly preserved upon substitution of this glycine 280 to
threonine mutation (G280T), as some cells survived up to a
concentration of 80MZnSO4 (Table 5). In addition, these cells
displayed slightly higher levels of Zinpyr-1 fluorescence com-
pared with the G280R mutant (Fig. 7a). All other substitutions
including G280L, G280Q, and G280K representing hydropho-
bic, polar, and cationic amino acid substitutions, respectively,
failed to protect the cells from zinc toxicity and were similar to
the G280R TNZD mutant (Table 5 and Fig. 7a). These results
suggest that a small, non-polar, non-hydrophobic and non-
charged amino acid is required in this position for proper func-
tion of ZnT2.
Next, we substituted the threonine residue at position 312 of
ZnT2 as shown inTable 5 and Fig. 7b. Substitution of threonine
312 by alanine (T312A), glutamate (T312E), or aspartate
(T312D) resulted in the loss of the ability of cells to protect
themselves against zinc toxicity; cells failed to survive ZnSO4
concentrations	60M, hence being similar to cells expressing
the TNZD T312M mutation. In contrast, replacement of this
residue with a nucleophilic amino acid such as serine (T312S)
or cysteine (T312C) markedly restored cell survival under high
zinc concentrations, with a slight advantage for the conserva-
tive serine substitution over cysteine. These results further sup-
port our findings that Thr-312 is presumably important for zinc
chelation and coordination, which are essential prerequisites
for zinc transport. Furthermore, we observed similar results in
the Zinpyr-1 accumulation assay as substitution of the Thr-312
residue with the nucleophilic amino acids serine (T312S) or
cysteine (T312C) significantly increased their ability to accu-
mulate Zinpyr-1 compared with the T312M mutant, hence
attaining the same Zinpyr-1 levels of the WT-ZnT2 (Fig. 7b).
Substitution of glutamate 355 to alanine (E355A), did not
improve zinc transport ability when compared with the E355Q
TNZD mutant, as ZnT1/MT/ZnT4/ cells expressing
E355Q or E355A were not able to tolerate ZnSO4 concentra-
tions	60M (Table 5). Furthermore, substitution of glutamate
355 to aspartate (E355D), which is the same amino acid that is
present at the parallel residue (Asp-285) of zinc coordination in
the bacterial YiiP, failed to rescue the zinc transport ability of
ZnT2, and thus cells succumbed at concentrations 	60 M
ZnSO4. In addition, the ability of these mutant transporter
expressing cells to accumulate Zinpyr-1 was similar to cells
FIGURE 7. Evaluationof the zinc transport activity of ZnT2mutants ofGly-280, Thr-312, orGlu-E355 residues using a viable fluorescent zinc-selective
probe, Zinpyr-1. The percent changes of Zinpyr-1 fluorescence were calculated by dividing the fluorescence levels (raw value of medians) obtained in cells
cultured in 30M ZnSO4 by that under normal growth conditions. Asterisks denote a significant difference (n 3, p 0.05) in the percent, comparedwith the
ZnT1/MT/ZnT4/ cells stably expressing TNZDmutants (G280R, T312M, or E355Q). Error bars represent S.D.
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expressing the E355QZnT2mutant (Fig. 7c). These results sug-
gest thatGlu-355 is crucial for zinc transport and compartmen-
talization, and emphasize that in contrast to YiiP, the aspartate
residue at position 355 in ZnT2 is not sufficient for zinc coor-
dination and cannot contribute to zinc transport function.
Thus, the consistent results we obtained in the two different
functional assays further strengthen the validity of these
findings.
Different Expression Levels of the Various Gly-280, Thr-312,
and Glu-355 Site-directed Mutants of ZnT2 in ZnT1/MT/
ZnT4/Cells—We determined the actual expression levels of
these different mutations using Western blotting analysis to
verify that the impaired function is not only due to low expres-
sion levels of the ZnT2 mutants (Fig. 8). We found that all
mutant ZnT2 proteins were expressed at lower levels than the
WT-ZnT2 protein (Fig. 8). However, these low expression lev-
els were sufficient to support a markedly improved survival of
cells expressing T312S or T312C proteins in a zinc toxicity
assay (Table 5), thereby suggesting that the low expression lev-
els are not the sole mechanism underlining the very low zinc
compartmentalization ability of the other ZnT2 mutants as
shown in Table 5 and Fig. 7.
Discussion
ZnT2 is a key mediator of zinc transport into vesicles in
mammary gland epithelial cells (2, 26). It is the sole transporter,
the loss of function of which was found to cause zinc-deficient
breast milk and TNZD (6–11, 27). Here we studied the impact
of three novel ZnT2 mutations recently identified in Japanese
mothers of infants displaying TNZD (11), on the structure, sta-
bility, subcellular localization, and zinc transport function.
These mutations, including G280R, T312M, and E355Q,
mapped to the C terminus of ZnT2 (Fig. 6) in contrast to the
G87R and W152R mutations that were found to be located in
TM domains (7, 8), whereas H54R localized at the N terminus
(6). Furthermore, these mutations mapped to ZnT2 residues
that are apparently crucial for zinc binding and translocation,
can shed light on the role of the C terminus of ZnT2 in protein
stability and zinc transport. Specifically, the g838 to a838 (gua-
nine 838 to adenine) mutation reduced splicing efficiency of
intron 6 in the ZnT2 transcript as shown previously (11). How-
ever, it is important to understand the impact of the G280R
mutation as it was a heterozygousmutation, the remainingWT
allele was not sufficient to support adequate zinc transport lev-
els into themilk.We found that upon intact splicing, theG280R
mutation altered the subcellular localization of ZnT2 and con-
sequently impaired vesicular zinc transport as reflected in the
loss of Zinquin and Zinpyr-1 accumulation. Furthermore, this
G280R mutation, which mapped to the distal part of the zinc
permeation pathway, could plausibly affect zinc coordination
and/or transport, based on the introduction of a new positively
charged Arg residue (Fig. 6), which is rather intriguing as it
renders ZnT2 more similar to YiiP in this particular region.
Despite that the close microenvironment of this Arg residue in
YiiP is not conserved in ZnT2, one cannot rule out the possible
existence of an alternative, nearby zinc coordination site on
ZnT2, or a zinc permeation pathway leading to zinc uptake into
cells. Thus, the G280R mutation may cause electrostatic and
steric interference, which may cause transporter protein desta-
bilization (11). The G280R mutation had multiple deleterious
effects including enhanced protein degradation, loss of vesicu-
lar localization, as well as the likely loss of zinc binding and
consequently a markedly impaired zinc transport (Table 2).
Substitutions of this residue to various amino acids demon-
strated the functional importance of a small amino acid residue
at this site. These findings are consistent with the severe phe-
notype that theG280Rmother harbored as the zinc levels in her
breast milk were very low (10 g/dl at 4 months postpartum;
normal range 80  30 g/dl) (11). Surprisingly, as revealed by
two independent and complementary assays including BiFC
and zinc toxicity, dimers of the mutant G280R together with
WT-ZnT2 retained some vesicular localization and Zinquin
accumulation function of the WT protein, thus demonstrating
that the G280R did not exert a dominant-negative effect over
the WT ZnT2.
In contrast to G280R, the T312M mutant displayed a minor
impact on subcellular localization ofWT-mutant ZnT2 dimers
as well as on dimer formation. However, from our multiple
analyses we can conclude that threonine 312 is an important
component of the zinc permeation pathway, and substitution of
this residue by a small or charged amino acid abolished zinc
transport function. This T312Mmutant was found to have the
least deleterious effect onWT-ZnT2 among the 3TNZDmuta-
tions studied here. This may also be related to the older age of
TNZD onset in the infant of the mother carrying this T312M
mutation (11).
FIGURE 8. Expression levels of the various Gly-280, Thr-312, and Glu-355
site-directedmutants of ZnT2 inDT40 ZnT1/MT/ZnT4/ cells.Con-
firmation of stable expression of the ZnT2-HA mutants in DT40 ZnT1/MT/
ZnT4/ cells. Western blotting analysis was performed using anti-ZnT2 and
-tubulin antibodies. Aliquots (10 g) of total cellular protein were loaded
onto each lane, and the samemembranewas used for detectionof bothZnT2
and -tubulin. -Tubulin is shown to estimate the actual loading of the
amount of proteins. represents untransfected cells.
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Finally, E355Q is the mutant that presumably had the most
deleterious effect on zinc coordination; moreover, our subcel-
lular localization findings reveal that thismutation significantly
altered the subcellular localization of ZnT2 dimers. These
results suggest that zinc coordination at this residue, which is
equivalent to site C in the bacterial YiiP transporter, has amajor
impact on protein stability. As such, substitution of this residue
negatively affected not only zinc transport but also the struc-
ture and subcellular localization of ZnT2. Site C in YiiP was
previously suggested to be critical for maintaining the stability
of the protein (28). In summary, these three TNZD mutations
markedly impaired the zinc transport function of ZnT2 in a
multi-factorial manner as depicted in summarizing Table 2.
Using the BiFC assay we were able to follow theWT-mutant
ZnT2 dimers and thereby determined the impact that specific
heterozygous ZnT2 mutations had on the WT ZnT2. If the
expression levels of the mutant andWT alleles are comparable
in the breastfeeding mother, one expects to obtain 50% of the
expressed protein in the homodimeric form composed of
mutant-WTdimers, in addition to 25% ofWTdimers as well as
25% of mutant-mutant dimers. As revealed by our flow cyto-
metric analysis, the mutant-WT dimers are significantly more
active in zinc transport than the mutant-mutant dimers, albeit
remain less active in zinc accumulation when compared with
WT homodimers. These results suggest that the residual activ-
ity of mutant-WT dimers is not sufficient to provide adequate
zinc secretion into the breast milk. As we and others previously
showed (16, 29), the refolding of the BiFC constructs into a fully
fluorescent YFP protein is an irreversible process. Hence, the
BiFC assay amplifies the percentage of the tagged BiFC dimers
that are detected and thereby one can easily follow the localiza-
tion and function of these various pairs. For example,
mutant-WT pairs, which were tagged with BiFC, were pre-
served at the dimer state, and therefore our measurements
mainly detected the function of these pairs. In contrast, in the
zinc toxicity assay, the expression of WT-ZnT2 together with
the mutant ZnT2, significantly compensated for the mutant
ZnT2 function; indeed, cells were readily capable of handling
almost the same zinc concentration of WT-ZnT2 expressing
cells. These results indicate that G280R, T312M, and E355Q
mutations did not significantly alter the function of the WT
ZnT2 upon co-expression, hence raising the question of why
mothers harboring a heterozygous ZnT2 mutation produced
breast milk that is very low in zinc and their infants presented
with a severe TNZD phenotype. Excluding one case of com-
pound ZnT2 mutations (7), it is noteworthy that all reported
cases of TNZD were heterozygous mutations. Although we
have previously shown that the G87Rmutation exerted a dom-
inant-negative effect over theWT-ZnT2 (8, 17), the vastmajor-
ity of other heterozygous inactivating ZnT2 mutations did not
appear to exert a dominant-negative effect on the WT allele.
Hence, although the inheritance pattern of TNZD has not yet
been established, it appears to be dominant even in the
heterozygote state. As a gradually increasing number of TNZD
cases associated with heterozygous mutations in ZnT2 was
recently reported, one can suggest that the unaffected WT
ZnT2 allele in TNZD cases is certainly not sufficient to provide
the necessary high levels of zinc in breast milk, which are
strictly required for proper growth and development of the
infant. Excluding cases of dominant-negative, such as theG87R
mutation, the above results suggest a haploinsufficiency state
for the unaffected WT ZnT2 allele in TNZD pathology. Fur-
thermore, the single case of premature stop codon (663delC),
which was dominantly inherited (9), lends further support for
haploinsufficiency, suggesting that one active copy of ZnT2 is
not sufficient for adequate zinc secretion into breast milk. This
lattermutation also strengthens the importance of the C termi-
nus of ZnT2 in zinc transport, as upon deletion of this region,
zinc levels in breast milk are clearly insufficient for the infant
(9).
In fact, there is ample evidence that haploinsufficiency in
heterozygous mutated transporter genes occurs in various dis-
eases: (a) maternal riboflavin deficiency, resulting in transient
neonatal-onset glutaric aciduria Type 2, is caused by amicrode-
letion in a single allele of the riboflavin transporter gene
GPR172B (30). The authors postulated that haploinsufficiency
of this riboflavin transporter causes riboflavin deficiency, and
when coupled with nutritional riboflavin deficiency in preg-
nancy, could result in the transient riboflavin-responsive dis-
ease observed in the newborn infant. (b) Darier’s disease, a skin
disease characterized by dark crusty patches on the skin (dysk-
eratosis folicularis), is inherited in an autosomal dominant
manner caused by heterozygous inactivating mutations in the
ATP2A2 gene (31). The latter encodes for the SERCA Ca2-
ATPase, which serves as an ATP-driven intracellular Ca2
pump located in the ER, hence actively concentratingCa2 into
the ER lumen. In a recent study a novel heterozygous splice site
mutation in the ATP2A2 gene was identified, hence suggesting
that despite heterozygous loss of function mutations in
ATP2A2, the dominant inheritance in Darier’s disease is due to
haploinsufficiency (32). (c) Two genes that have been impli-
cated as conferring susceptibility to autism spectrum disorder
are phosphatase and tensin homolog (PTEN) and serotonin
transporter (SLC6A4) (33). Recent studies in mice have con-
cluded that haploinsufficiency occurs for mutant PTEN and
serotonin transporter, which cooperatively influence brain size
and social behavior. This is due to heterozygous mutations in
both PTEN and serotonin transporter (33). As discussed above,
it is likely that, in mammary epithelial cells, the expression of
one WT ZnT2 allele is not sufficient for the secretion of ade-
quate zinc levels into breast milk. It was previously shown for
the BRACA1 gene that a heterozygous mutation is sufficient to
largely increase the risk for cancer development in specific epi-
thelial tissues like breast and ovary (34) with description of a
uniquemechanism, which contributes to tissue-specific cancer
development. This may suggest that there is a specific mecha-
nism that causes haploinsufficiency ofZnT2 inmammary gland
epithelial cells, as based on the current knowledge,ZnT2muta-
tions are not known to affect other tissues and organs and did
not induce other related symptoms in women carrying these
mutations. However, post-translational modifications at the C
terminus of ZnT2 were recently shown to be responsible for an
altered subcellular localization of ZnT2 from early endosomes
to lysosomes upon weaning (35). It will be interesting to inves-
tigate the effect of these different ZnT2mutations presented in
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the present study, all of which localized to the C terminus of
ZnT2, on its localization during the weaning period.
In summary, our current findings regarding the mode of
inheritance of TNZD suggest an autosomal dominant inherit-
ance, although further studies with additional TNZD cases are
required to establish this putative dominant autosomal inher-
itance. Based on a recent report, we have noticed that the case
numbers of TNZD in Japanese women were significantly
increasing in the past decade (11). These findings indicate that
the number of TNZD cases may be higher than initially pre-
dicted, and may further increase with the encouragement of
exclusive breast feeding, which is one of the main goals of the
WorldHealthOrganization (WHO). In fact, to date only 38% of
infants are exclusively breastfed globally, the WHO claims to
increase exclusive breastfeeding to at least 50% ofmothers until
6 months of age, by the year 2025. Further studies regarding
new ZnT2 mutations that cause TNZD in populations of dis-
tinct ethnicities are crucial for preventing morbidity of TNZD
using proper genetic screening.
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